| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |